Xiangyuan Luo
- Topics
- RNA modifications and cancer (4 papers)RNA Research and Splicing (4 papers)Cancer Mechanisms and Therapy (3 papers)
- Cited by
- Cancer ResearchHepatologyPhysiology
- Partner nations
- ChinaSouth Korea
In The Last Decade
Xiangyuan Luo
19 papers receiving 693 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 391
- Cancer Research 178
- Oncology 151
- Immunology 127
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Xiangyuan Luo
This map shows the geographic impact of Xiangyuan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyuan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyuan Luo more than expected).
Fields of papers citing papers by Xiangyuan Luo
This network shows the impact of papers produced by Xiangyuan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyuan Luo. The network helps show where Xiangyuan Luo may publish in the future.
Co-authorship network of co-authors of Xiangyuan Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyuan Luo. A scholar is included among the top collaborators of Xiangyuan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyuan Luo. Xiangyuan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 17 | |
| 3 | 8 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2breakdown → | 112 |
| 7 | 19 | |
| 8 | 21 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 27 | |
| 12 | 6 | |
| 13 | 15 | |
| 14 | 38 | |
| 15 | 9 | |
| 16 | Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targetsbreakdown → | 140 |
| 17 | 140 | |
| 18 | 60 | |
| 19 | 71 |
About Xiangyuan Luo
Xiangyuan Luo is a scholar working on Cancer Research, Hepatology and Physiology, having authored 19 papers that have together received 698 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Cancer Research (178 citations), Hepatology (68 citations) and Physiology (28 citations). Xiangyuan Luo has collaborated with scholars based in China and South Korea. Frequent co-authors include Xingxing He, Kongming Wu, Limin Xia, Wenjie Huang, Yijun Wang, Yangyang Feng, Mengyu Sun, Xiaoyu Ji, Fan Gao and Bixiang Zhang. Their work appears in journals such as Oncogene, Journal of Hepatology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.